NOS1 and muscular dystrophy: Absence or reduction of sarcolemmal nNOS has also been reported in non-DAPC-related muscular dystrophies (eg. LGMD2B, MDC1A) [29, 50], inflammatory myopathies [50], cachexia [51], myasthenia gravis [26], diabetes [52], and aging-related muscle atrophy [53].